NICE (@NICEComms) / X

NICE

17.2K posts

NICE

@NICEComms

Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.

London and Manchester, UK

Joined October 2009

NICE
@NICEComms
1h
We’ve recommended tisotumab vedotin for advanced cervical cancer. It belongs to a class of medicines called antibody-drug conjugates, which target and deliver cancer-killing medicine directly to tumour cells. Read the final guidance here: nice.org.uk/guidance/ta1164
272
NICE
@NICEComms
7h
This morning, our programme director for healthech strategy and development, Sarah Byron, was discussing AI at #NHSConfed2026. Sarah was joined on a panel talking about the AI shift in urgent diagnostics. #NHSConfedExpo
511
NICE
@NICEComms
Jun 10
Our programme director for healthech strategy and development, Sarah Byron, joined a panel this afternoon at #NHSConfed2026. Sarah was talking about turning the National Cancer Plan into UK cancer outcomes. #NHSConfedExpo
802
NICE
@NICEComms
Jun 10
NICE healthtech director Thomas Slater is on the panel at #NHSConfed2026, exploring how innovation moves from research to real-world NHS adoption. 👉Developing or adopting healthtech? Explore support: nice.org.uk/what-nice-does… #BackingTheHealthtechThatChangesLives #HealthTech
652
NICE
@NICEComms
Jun 10
Our programme director for medicines evaluation, Jacoline Bouvy, discussing medicines policy in the new NHS operating model and what this means for organisations across health and social care. Jacoline is one of four of our experts joining panels at #NHSConfed2026
804
NICE
@NICEComms
Jun 10
We're delighted to be at #NHSConfed2026 Come and talk to us about how NICE guidance can support your organisation - you'll find us at stand B19. You can also hear from our experts who are on 4 panels over the 2 days.
762
NICE
@NICEComms
Jun 8
Heading to #NHSConfed2026 this week? Our experts will be on two panels on day 1 — covering medicines policy in the new NHS operating model and how innovation gets from research to real-world adoption. Come and find us at stand B19.
00:00
1.2K
NICE
@NICEComms
Jun 8
This #DiabetesAwarenessWeek, meet Aleix. T1D meant constant calculations and saying no to life. A hybrid closed loop device changed everything: less worry, better sleep, more freedom. youtube.com/watch?v=q2K18q… 👉Explore healthtech support: nice.org.uk/what-nice-does…
1.8K
NICE
@NICEComms
Jun 8
Today, NICE has published guidance recommending daratumumab with bortezomib, lenalidomide and dexamethasone as an option for people with untreated multiple myeloma when a stem cell transplant is unsuitable. Read the final draft guidance here: nice.org.uk/guidance/indev…
1.8K
NICE
@NICEComms
Jun 5
🎧NEW NICE Talks: Treating babies at home with oral antibiotics. New NICE guidance could mean shorter hospital stays for some newborns - by switching to oral antibiotics at home. Hear insights from clinicians and a parent’s experience. Listen now👇 soundcloud.com/nicecomms/trea…
00:00
1.2K
NICE
@NICEComms
Jun 4
Thousands of people living with a chronic liver condition are set to benefit from a new daily pill that tackles both the disease itself and the persistent, severe itching it causes. Find out more about seladelpar: nice.org.uk/guidance/indev…
868
NICE
@NICEComms
Jun 4
NICE has recommended mirvetuximab soravtansine for NHS patients with platinum-resistant ovarian cancer. The first new treatment recommended for this condition in over 20 years. Learn more: nice.org.uk/news/articles/…
1.1K
NICE
@NICEComms
Jun 3
The first immunotherapy for people with an aggressive form of stomach cancer has been recommended in final guidance published today. Durvalumab is recommended for over 1,500 people a year: nice.org.uk/news/articles/…
1.4K